ArticleThe Journal of reproduction and development2026
Functional glucocorticoid system in bovine oviduct epithelial cells attenuates lipopolysaccharide induced inflammatory responses.
Article in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bovine oviduct supports early reproductive events that require a balance between immune defense and tolerance. Glucocorticoids are well-known immune modulators; however, their presence, regulation, and functional relevance in the bovine oviduct remain poorly understood. This study investigated the presence and role of the corticosteroid system in the bovine oviduct and cultured bovine oviduct epithelial cells (BOECs). Bovine oviducts were collected during estrous cycle, fixed in 4% paraformaldehyde and processed for immunohistochemistry. BOECs were harvested from the ampulla and isthmus and cultured under sequential progesterone and estradiol treatment to mimic estrous cycles. On day 8, which equivalent to post‑ovulation day 1 in vivo, cells were treated with lipopolysaccharide (LPS; 1 μg/ml), cortisol (100 nM), cortisone (100 nM), or their combinations for 24 h. After culture, cells were harvested for gene analysis by RT-PCR, while spent media were collected for cortisol measurement by ELISA. Immunohistochemistry revealed predominant epithelial localization of NR3C1, NR3C2, HSD11B1, and HSD11B2 in both ampulla and isthmus. During 7-day preculture, expression of NR3C1 and HSD11B1 persisted, whereas that of NR3C2 and HSD11B2 declined sharply. LPS treatment on day 8 sharply upregulated TLR2, TNF, IL1B, IL6, CXCL8 and HSD11B1, whereas the concomitant treatment with cortisol suppressed all LPS-induced cytokines. BOECs were capable to convert added cortisone to cortisol, and LPS doubled this through up-regulating HSD11B1. Locally produced cortisol also suppressed LPS-induced cytokines. Collectively, these findings demonstrate that BOECs possess a functional glucocorticoid system, capable of producing cortisol from cortisone, which in turn suppresses LPS-induced inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.